05:40 AM EDT, 05/04/2026 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We cut our 12-month target price by $29 to $340, or 25.0x our 2027 EPS estimate, vs. LHX's three-year average forward P/E of 19.6x and peers' average forward P/E of 22.0x. We lower our 2026 EPS estimate by $0.21 to $12.04 and drop our 2027 EPS estimate to $13.60 from $14.76. LHX delivered strong Q1 2026 results with 15% organic sales growth. LHX's record backlog of $40.7B (up significantly with a 1.4x book-to-bill) provides strong revenue visibility, particularly given anticipated $25B in additional Munitions Acceleration Council orders. LHX is experiencing growth across Space & Mission Systems (up 24% Y/Y in Q1), missionized aircraft, and software-defined communications, with international orders that are particularly strong (2.2x book-to-bill). While the 2028 framework (three-year plan) targets industry-leading growth, near-term execution risks remain around capacity expansion, supply chain constraints, and the complexity of the Missile Solutions separation, tempering our outlook despite the strong momentum.